By Drug Target Review2025-11-03T09:29:05
Scientists have developed two rapid and affordable blood tests that can detect early markers of Alzheimer’s disease – potentially decades before symptoms appear.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-03-08T16:29:20
Sponsored by Bio-Techne
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud